InvestorsHub Logo
Followers 155
Posts 2632
Boards Moderated 0
Alias Born 01/29/2004

Re: None

Wednesday, 05/22/2024 8:41:53 AM

Wednesday, May 22, 2024 8:41:53 AM

Post# of 461360
More Drug Development Processionals Destined to Failure

Reinforcing the Company’s commitment to drive value-creation through operational efficiencies and innovation in the industry, Anavex announces new additions to its leadership team with the appointment of Juan Carlos Lopez-Talavera, MD, PhD as Senior Vice President, Head of Research and Development, Terrie Kellmeyer, PhD as Senior Vice President of Clinical Development, and Jeffrey Edwards, PhD as Vice President of Clinical Pharmacology and Science.

https://www.anavex.com/post/anavex-life-sciences-announces-expansion-of-leadership-team?mc_cid=48c15345b0&mc_eid=39975e48cc

Once again, otherwise knowledgeable and experienced drug development professionals have so enigmatically decided to sign on with Anavex — as though that company and its drugs had some sort of future they could create. So little do they know.

Sadly, these people have spent no time on this public message board assessing the deep knowledge of the many Anavex naysayers who so expertly and convincingly tell why Anavex and its CEO are failures; with no future whatsoever in being able to manufacture or sell any drug.

In ignorance of all of that, these people have staked the next chapters of their professional careers on Anavex Life Science Corp. We can feel so sorry for these people, can’t we?

(Well, no. They know more about Anavex than anyone who posts on this message board. What, do you suppose, they demanded and got to see before they signed on?)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News